In mouse models of carcinogenesis, it was reported that NF-κB activation increased Wnt/β-catenin signaling activity and induced the dedifferentiation of non-stem cells that acquired tumor-initiating capacity [57]. This evidence concerns the gene NFKB1 and neoplasm.